Carbon Nanotube Composite for Biomedical Applications ID: 2012-061
A novel carbon nanotube composite technology aimed at enhancing the performance and biocompatibility of cardiovascular stents.
Photo by Alex Traveler - stock.adobe.com
Technology Overview
This technology involves the creation of carbon nanotube arrays infiltrated with various materials such as pyrolytic carbon, polymers, or magnesium. Designed to improve biomedical devices, its primary focus is on cardiovascular stents, offering solutions to common complications like restenosis and thrombosis. The unique fabrication process allows for precise control over the stent's dimensions and material properties, setting it apart from current market offerings.
Key Advantages
- Enhanced biocompatibility reducing the risk of restenosis and thrombosis
- Fine control over dimensions and material properties for customized applications
- Versatility in material infiltration (pyrolytic carbon, polymers, magnesium) for various needs
- Potential for broader biomedical device applications beyond stents
Problems Addressed
- Reduction in the occurrence of restenosis and thrombosis in coronary stents
- Lack of customizability and adaptability in existing stent technologies
- Limitations in biocompatibility of current cardiovascular stents
Market Applications
- Cardiovascular stents for hospitals and medical device companies
- Biomedical devices requiring enhanced biocompatibility and precision in design
- Research and development in advanced materials for medical applications
Additional Information
Technology ID: 2012-061
Sell Sheet: Download the Sell Sheet here
Market Analysis: Contact us for a more in-depth market report
Date Published: 01 July, 2025
Connect with the Tech Transfer to:
- Meet with the technology manager
- Receive additional information
- Request a marketing plan report